BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mallet V, Hamed K, Schwarzinger M. Prognosis of patients with chronic hepatitis B in France (2008–2013): A nationwide, observational and hospital-based study. Journal of Hepatology 2017;66:514-20. [DOI: 10.1016/j.jhep.2016.10.031] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Wedemeyer H, Negro F. Devil hepatitis D: an orphan disease or largely underdiagnosed? Gut 2019;68:381-2. [PMID: 30368454 DOI: 10.1136/gutjnl-2018-317403] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
2 Li X, Jiao Y, Xing Y, Gao P. Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis. Biomed Res Int. 2019;2019:5308308. [PMID: 31080822 DOI: 10.1155/2019/5308308] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
3 Liang N, Kong Z, Ma SS, Lu CL, Yang M, Feng LD, Shen C, Diao RH, Cui LJ, Lu XY, Nikolova D, Jakobsen JC, Gluud C, Liu JP. Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B. Cochrane Database Syst Rev 2019;4:CD013089. [PMID: 30941748 DOI: 10.1002/14651858.CD013089.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Liang N, Kong Z, Lu CL, Ma SS, Li YQ, Nikolova D, Jakobsen JC, Gluud C, Liu JP. Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B. Cochrane Database Syst Rev 2019;6:CD013106. [PMID: 31232459 DOI: 10.1002/14651858.CD013106.pub2] [Reference Citation Analysis]
5 Kim HN. Chronic Hepatitis B and HIV Coinfection: A Continuing Challenge in the Era of Antiretroviral Therapy. Curr Hepatol Rep 2020;19:345-53. [PMID: 33796434 DOI: 10.1007/s11901-020-00541-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kamal H, Fornes R, Simin J, Stål P, Duberg AS, Brusselaers N, Aleman S. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies. J Viral Hepat 2021. [PMID: 34291520 DOI: 10.1111/jvh.13577] [Reference Citation Analysis]
7 Parlati L, Sogni P, Mallet V. [Care pathways and outcome of chronic HBV infection: Big data see the forest for the trees]. Presse Med 2017;46:791-3. [PMID: 28935444 DOI: 10.1016/j.lpm.2017.06.017] [Reference Citation Analysis]
8 Campbell C, Wang T, McNaughton AL, Barnes E, Matthews PC. Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis. J Viral Hepat 2021;28:493-507. [PMID: 33305479 DOI: 10.1111/jvh.13452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kong Z, Liang N, Yang GL, Zhang Z, Liu Y, Yang Y, Liu YX, Wang QG, Zhang F, Zhang HY, Nikolova D, Jakobsen JC, Gluud C, Liu JP. Acupuncture for chronic hepatitis B. Cochrane Database Syst Rev 2019;8:CD013107. [PMID: 31436846 DOI: 10.1002/14651858.CD013107.pub2] [Reference Citation Analysis]
10 Scarponi CFO, Pedrosa MAF, Mol MPG, Hardman MJM, Greco DB. Low eligibility for hepatitis B treatment in the Brazilian public health system. Rev Soc Bras Med Trop 2022;55:e02972021. [PMID: 35416869 DOI: 10.1590/0037-8682-0297-2021] [Reference Citation Analysis]
11 Kong DZ, Liang N, Yang GL, Zhang Z, Liu Y, Yang Y, Liu YX, Wang QG, Zhang F, Zhang HY, Nikolova D, Jakobsen JC, Gluud C, Liu JP; Cochrane Hepato-Biliary Group. Acupuncture for chronic hepatitis B. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013107] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Schwarzinger M, Baillot S, Yazdanpanah Y, Rehm J, Mallet V. Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008-2013: A nationwide retrospective cohort study. J Hepatol 2017;67:454-61. [PMID: 28396173 DOI: 10.1016/j.jhep.2017.03.031] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
13 Younossi Z, Kochems K, de Ridder M, Curran D, Bunge EM, de Moerlooze L. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease. Hum Vaccin Immunother 2017;13:2695-706. [PMID: 28742983 DOI: 10.1080/21645515.2017.1353850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
14 Bixler D, Zhong Y, Ly KN, Moorman AC, Spradling PR, Teshale EH, Rupp LB, Gordon SC, Boscarino JA, Schmidt MA, Daida YG, Holmberg SD, Holmberg SD, Teshale EH, Spradling PR, Moorman AC, Xing J, Zhong Y, Gordon SC, Nerenz DR, Lu M, Lamerato L, Li J, Rupp LB, Akkerman N, Zhang T, Trudeau S, Zhou Y, Wu K, Boscarino JA, Daar ZS, Smith RE, Daida YG, Trinacty CM, Lai JW, Wong CP, Schmidt MA, Donald JL; CHeCS Investigators. Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS). Clinical Infectious Diseases 2019;68:956-63. [DOI: 10.1093/cid/ciy598] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
15 Liang N, Kong DZ, Nikolova D, Gluud C, Jakobsen JC, Liu JP; Cochrane Hepato-Biliary Group. Radix Sophorae flavescentis for chronic hepatitis B. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013089] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Lieveld FI, Smit C, Richter C, van Erpecum KJ, Spanier BWM, Gisolf EH, Vrolijk JM, Siersema PD, Hoepelman AIM, Reiss P, Arends JE. Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection. Liver Int 2019;39:470-83. [PMID: 30411848 DOI: 10.1111/liv.14000] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
17 Zhao Y, Xing H, Wang X, Ou W, Zhao H, Li B, Li Y, Duan Y, Zhuang L, Li W, Cheng D, Quan M, Zhang Y, Ji S. Management of Diabetes Mellitus in Patients with Chronic Liver Diseases. J Diabetes Res 2019;2019:6430486. [PMID: 31915709 DOI: 10.1155/2019/6430486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
18 Ly KN, Yin S, Spradling PR. Regional Differences in Mortality Rates and Characteristics of Decedents With Hepatitis B Listed as a Cause of Death, United States, 2000-2019. JAMA Netw Open 2022;5:e2219170. [PMID: 35763293 DOI: 10.1001/jamanetworkopen.2022.19170] [Reference Citation Analysis]
19 Rajoriya N, Combet C, Zoulim F, Janssen HLA. How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach? J Hepatol. 2017;67:1281-1297. [PMID: 28736138 DOI: 10.1016/j.jhep.2017.07.011] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 13.4] [Reference Citation Analysis]